Skip to main content

Table 1 Baseline features of the study cohort and the results of univariable logistic regression analysis

From: Associations of single nucleotide polymorphisms with mucinous colorectal cancer: genome-wide common variant and gene-based rare variant analyses

  

Mucinous

Non-mucinous

  

Characteristics

No. (%)

No. (%)

OR (95% CI)

p-value

Agea

≤60

20 (9)

203 (91)

  

60–65

17 (18)

78 (82)

2.21 (1.09–4.44)

0.025

>65

20 (11)

167 (89)

1.22 (0.63–2.34)

0.558

Sex

Female

29 (15)

169 (85)

  

Male

28 (9)

279 (91)

0.58 (0.34–1.02)

0.057

Location

Colon

47 (14)

287 (86)

  

Rectum

10 (6)

161 (94)

0.38 (0.18–0.74)

0.007

Stage

I

3 (3)

90 (97)

  

II

27 (14)

169 (86)

4.79 (1.64–20.45)

0.012

III

19 (11)

147 (89)

3.88 (1.28–16.83)

0.033

IV

8 (16)

42 (84)

5.71 (1.57–27.09)

0.013

Grade

Well/moderately diff.

48 (10)

416 (90)

  

Poorly diff.

7 (19)

30 (81)

2.02 (0.78–4.62)

0.115

Unknown

2

2

  

MSI status

MSI-low/MSS

49 (11)

382 (89)

  

MSI-high

6 (11)

47 (89)

1.00 (0.37–2.29)

0.992

Unknown

3

18

  

Lymphatic

invasion

Absent

31 (10)

267 (90)

  

Present

23 (14)

144 (86)

1.38 (0.77–2.44)

0.278

Unknown

3

37

  

BRAF V600E

mutation

Absent

45 (11)

366 (89)

  

Present

9 (19)

38 (81)

1.93 (0.83–4.09)

0.104

Unknown

3

44

  
  1. aThe age at diagnosis was separated into 3 groups: ≤60, 60–65, and > 65 since the odds ratio does not remain constant for each year increase in age at diagnosis under the logistic regression model and this particular grouping gave the most efficient odds ratio estimates with no significant change in the results when considering slightly different groupings. CI confidence interval, diff. Differentiated, MSI microsatellite instability, MSS microsatellite stable, No number, OR odds ratio (compares the odds of having mucinous tumors with the corresponding factor level to the odds of having mucinous tumors with the reference factor level)